baber/WOPTO huggingface dataset:
Patent AU-2011318934-B2 (AU)
Title: Transmission control device, hybrid automobile, transmission control method, and program
Inventor: ARAKI TOMOHIKO
IPC: B60L50/16
Filed: 2011-10-20
Granted: 2015-12-17
Abstract: To improve the drivability of an automobile at the time of transmission which restricts a torque of an engine. A hybrid automobile is structured which performs transmission control for performing control so that an output restriction is temporarily released in a step of restoring a torque that is reduced once in neutral at the time of transmission during the output restriction by an output restriction control unit and a torque by a motor is added to the torque of the engine.
Patent AU-2011335073-B2 (AU)
Title: Dispense interface component for a drug delivery device
Inventor: HOLTWICK MARC
IPC: A61M5/20
Filed: 2011-11-28
Granted: 2015-02-05
Abstract: A dispense interface component for use with a drug delivery device is provided. The dispense interface component may include a main body (14), a first piercing portion (1208), a second piercing portion (1212), and a biasing element. The main body is configured for connection to the drug delivery device. The first piercing portion is for piercing a first cartridge (1210) contained within the drug delivery device, and the first piercing portion is connected to the main body. The second piercing portion is for piercing a second cartridge (1214) contained with the drug delivery device, and the second piercing portion is connected to the main body. The at least one biasing element (1216) is operably coupled to the main body, wherein the at least one biasing element is configured to, when the load on the at least one biasing element is less than or equal to a threshold load, bias (i) the first piercing portion away from the first cartridge and (ii) the second piercing portion away from the second cartridge.
Patent AU-2011343392-B2 (AU)
Title: CD89 activation in therapy
Inventor: VON GUNTEN STEPHAN
IPC: A61K39/395
Filed: 2011-12-14
Granted: 2017-01-05
Abstract: The invention relates to the use of CD89 activating molecules, in particular Fc alpha comprising molecules, and more particularly, IgA, for inducing apoptosis in neutrophils. Anti-CD89 antibodies can alternatively be used. The CD89 activation is beneficial in the treatment of various disorders associated with increases in neutrophils, such as autoimmune disorders, inflammatory disorders, NETosis, or cystic fibrosis.
Patent AU-2011380514-B2 (AU)
Title: Statistical reservoir model based on detected flow events
Inventor: SHIRZADI SHAWN
IPC: E21B43/20
Filed: 2011-11-18
Granted: 2016-10-13
Abstract: Computerized method and system for deriving a statistical reservoir model of associations between injecting wells and producing wells. Potential injector events at which injection flow rate changes are interactively identified from time series measurement data of flow rates at the wells in a production field, with confirmation that some response to those injector events appears at producing wells. Gradient analysis is applied to cumulative production time series of the producing wells, to identify points in time at which the gradient of cumulative production changes by more than a threshold value. The identified potential producer events are spread in time and again thresholded. An automated association program rank orders injector-producer associations according to strength of the association. A capacitance-resistivity reservoir model is evaluated, using the flow rate measurement data, for the highest-ranked injector-producer associations. Additional associations are added to subsequent iterations of the reservoir model, until improvement in the uncertainty in the evaluated model parameters is not statistically significant.
Patent AU-2012203322-B2 (AU)
Title: B-Cell Reduction Using CD37-Specific And CD20-Specific Binding Molecules
Inventor: LEDBETTER JEFFREY A
IPC: C07K16/28
Filed: 2012-06-06
Granted: 2014-07-10
Abstract: The present invention generally provides methods for B-cell reduction in an individual using CD37-specific binding molecules. In particular, the invention provides methods for B-cell reduction using CD37-specific binding molecules alone, or a combination of CD37-specific binding molecules and CD20-specific binding molecules, in some instances a synergistic combination. The invention further provides materials and methods for treatment of diseases involving aberrant B-cell activity. In addition, the invention provides humanized CD37 specific binding molecules.
Patent AU-2012203597-B2 (AU)
Title: A Distribution Pipeline Power Plant
Inventor: FLETCHER PAUL
IPC: F03G4/00
Filed: 2012-06-20
Granted: 2016-10-27
Abstract: A DISTRIBUTION PIPELINE POWER PLANT A distribution pipeline power plant, comprising: an input, configured to receive a fluid that has been heated using energy derived from a geothermal field; 10 an expander, configured to extract energy from the fluid that has been heated using energy derived from a geothermal field; and an output configured to transfer at least some of the energy extracted from the fluid that has been heated using energy derived from a geothermal field to a circulator to drive a further fluid along a distribution pipeline. 14- 12 2 6 --- -- 46 --.----.---. 26 -- } 26 48_50
Patent AU-2012247045-B2 (AU)
Title: Apparatus and method for measuring biologic parameters
Inventor: ABREU MARCIO MARC AURELIO MARTINS
IPC: A61B5/00
Filed: 2012-11-02
Granted: 2014-05-22
Abstract: Support structures for positioning sensors on a physiologic tunnel for measuring physical, chemical and biological parameters of the body and to produce an action according to the measured value of the parameters. The support structure includes a sensor fitted on the support structures using a special geometry for acquiring continuous and undisturbed data on the physiology of the body. Signals are transmitted to a remote station by wireless transmission such as by electromagnetic waves, radio waves, infrared, sound and the like or by being reported locally by audio or visual transmission. The physical and chemical parameters include brain function, metabolic function, hydrodynamic function, hydration status, levels of chemical compounds in the blood, and the like. The support structure includes patches, clips, eyeglasses, head mounted gear and the like, containing passive or active sensors positioned at the end of the tunnel with sensing systems positioned on and accessing a physiologic tunnel. 7~~- 1 ... .... 'I Ell4 F.,, L r
Patent AU-2012268869-B2 (AU)
Title: Fuel injection controller
Inventor: YAMAMURA YOSHIYA
IPC: F02D41/40
Filed: 2012-12-24
Granted: 2014-09-25
Abstract: In a fuel injection controller 100, a duration timer 19 measures an intertooth interval from when a pickup detects a tooth of a pulser to when it detects a next tooth. A calculation unit 15 specifies an injection timing for each cylinder by using the intertooth interval stored in a storage unit 18. The storage unit 18 renews the stored intertooth interval with a newly input intertooth interval of a tooth of the same number as a tooth of the stored intertooth interval. When a determination unit 17 determines that the intertooth interval to be used for specifying the injection timing corresponds to an intertooth interval of a missing tooth zone 13a, the calculation unit 15 converts and uses the intertooth interval to be used based on the number of the tooth most recently detected by the pickup when the intertooth interval is used. or C I Ud COC tCD
Patent AU-2012278832-B2 (AU)
Title: Multiple-enzyme nanocomplexes
Inventor: LU YUNFENG
IPC: C12N9/00
Filed: 2012-07-06
Granted: 2017-04-20
Abstract: Provided are nanocomplexes having at least two different enzymes and a polymeric network anchored to at least one of the enzymes. In some embodiments, the activities of the enzymes catalyze a cascade reaction.
Patent AU-2012320835-B2 (AU)
Title: Belt having embedded tension members
Inventor: GIBSON DANIEL PATTIE
IPC: F16G1/10
Filed: 2012-10-04
Granted: 2016-03-17
Abstract: In a force transmission belt or a conveyor belt, in particular a toothed belt, having a main belt body or a cord embedding zone made of a customary belt elastomer (20), in particular of polyurethane, and having at least one tension member of carbon cord (10; 1, 2) embedded in the elastomer (20), a material (30) is provided, which is enclosed between the strands (1) of the cord (10), and which could have been introduced by applying coatings onto strands (1) of the cord (10), for example. Said filler material (30), which is different from the elastomer (20) in which the carbon cord is embedded, consists of a composition of hydroxyaromates and aldehydes, without any addition of rubber or rubber latex, a hydroxyaromates-aldehyde resin that does not contain rubber, reaction products from hydroxyaromates or hydroxyaromates-aldehyde compositions with isocyanates or isocyanate prepolymers, and/or aromatically or polyaromatically cross-linked polyurethanes, or contains these substances. The elasticity of the carbon cord (10; 1, 2) is thus successfully maintained, good integration in the belt elastomer (20) is ensured, and the service time of the belt is substantially increased.
Patent AU-2012362983-B2 (AU)
Title: Peel ply, method of surface preparation and bonding composite structures using the same
Inventor: ZHAO YIQIANG
IPC: B29C37/00
Filed: 2012-11-16
Granted: 2016-11-10
Abstract: A resin-rich peel ply (11) that does not leave behind residual fibers after peeling and can work well with different resin-based composite substrates (10) The resin-rich peel ply (11) is composed of a woven fabric (lib) impregnated with a resin matrix (11a) different from the resin matrix of the composite substrate (10). The peel ply (11) is designed such that, upon manual removal of the peel ply (11) from the composite substrate's (10) surface, a thin film of the peel ply resin remains on the composite substrate's surface to create a bondable surface capable of bonding with another composite substrate (12), but no fibrous material from the woven fabric remains on the same surface.
Patent AU-2012384311-B2 (AU)
Title: Vane-type fluid transmission apparatus
Inventor: YANG GENE-HUANG
IPC: F04C2/344
Filed: 2012-06-29
Granted: 2016-07-28
Abstract: A vane-type fluid transmission apparatus comprises a stator (10), a rotor (20), at least one vane (34), at least one first lining (40), and at least one second lining (50). A chamber (13) is formed in the stator (10), and the chamber communicates with the outside through a flow channel. The rotor (20) comprises a body (21) and a main shaft (22). The main shaft (22) is connected to the body (21). The body (21) is eccentrically set in the chamber (13); the periphery of the body (21) tangentially contacts the inner wall of the chamber (13), and the body (21) is provided with at least one radial groove (23). The vane (34) is pivotally embedded in the groove (23), and contacts the inner wall of the chamber (13). The first lining and the second lining are separately and pivotally embedded in the stator (10), and revolve around the circular centre of the chamber. The vane is pivotally connected to the first lining and the second lining, causing the vane to revolve around the circular centre of the chamber while moving in a reciprocating manner in the groove. One end of the vane in contact with the inner wall of the chamber forms an arc surface, causing the end of the vane to keep in tangential contact with the inner wall of the chamber, thus improving the efficiency of fluid pump-through transmission and reducing the difficulty of manufacturing the stator to form a chamber.
Patent AU-2012396236-B2 (AU)
Title: DGAT genes comprising pleckstrin homology domains and use in recombinant microorganisms
Inventor: COPPERSMITH JENNIFER
IPC: C12N5/10
Filed: 2012-12-06
Granted: 2015-10-15
Abstract: The present invention provides novel diacylglycerol acyltransferase (DGAT) genes comprising Pleckstrin Homology (PH) domains. The present invention also provides for recombinant cells, such as algae, transformed with acyltransferase genes, such as DGAT, comprising PH domains, and methods of using such recombinant cells to produce increased triglyceride levels.
Patent AU-2013206215-B2 (AU)
Title: Positively charged water-soluble prodrugs of aspirin
Inventor: XU LINA
IPC: C07C235/16
Filed: 2013-06-07
Granted: 2016-06-02
Abstract: POSITIVELY CHARGED WATER-SOLUBLE PRODRUGS OF Abstract The novel positively charged prodrugs of acetylsalicylic acid and its analogues in the general formula (1) "Structure 1" were designed and synthesized. The compounds of the general formula (1) "Structure 1" indicated above can be prepared from functional derivatives of ASA or its analogues, (for example acid halides or mixed anhydrides), by reaction with suitable alcohols, thiols, or amines. The positively charged amino groups of these pro-drugs not only largely increases the solubility of the drugs, but also bonds to the negative charge on the phosphate head group of membranes and push the pro-drug into the cytosol. The experiment results suggest that the pro-drug, diethylaminoethyl acetylsalicylate.AcOH, diffuses through human skin ~400 times faster than acetylsalicylic acid itself and ~100 times faster than ethyl acetylsalicylate. In plasma, 80% of these pro-drugs can change back to the drug in a few minutes. The pro-drugs can be used medicinally in treating any aspirin-treatable conditions in humans or animals and be administered not only orally, but also transdermally for any kind of medical treatments and avoid most of the side effects of aspirin, most notably GI disturbances such as dyspepsia, gastroduodenal bleeding, gastric ulcerations, and gastritis. Controlled transdermal administration systems of the prodrug enables the aspirin to reach constantly optimal therapeutic blood levels to increase effectiveness and reduce the side effects of aspirin.
Patent AU-2013206289-B2 (AU)
Title: Sample testing apparatus and method
Inventor: PIRES FABIO DE SOUZA
IPC: G01N17/02
Filed: 2013-06-12
Granted: 2016-09-22
Abstract: SAMPLE TESTING APPARATUS AND METHOD A test apparatus (12) and a method of testing a sample (30) are disclosed. The method comprises receiving a test 5 sample (30) within a test chamber (14), the test chamber (14) containing two or more iron saturation elements (2) separated by a spacer (16); and filling the test chamber (14) with a test solution, the iron saturation elements (2) being arranged to saturate the test solution with 10 iron. Each iron saturation element (2) is shaped such that it has a predetermined surface area such that the ratio of the volume of the test solution to the surface area of the iron saturation elements (2) and the test sample (30) exposed to the test solution can be 15 calculated. 4423001_1 (GHMatters) P93943.AU 12/06/13 ,20 FIG. 2 FIG.___ -
Patent AU-2013210416-B2 (AU)
Title: Desrhamnosyl acteoside-containing olive extract
Inventor: FUKUI YUKO
IPC: A61K31/7034
Filed: 2013-01-17
Granted: 2017-03-23
Abstract: Provided are food and drink, a non-medicinal product, and a medicine in which high antioxidant effect is exhibited over a long period of time in vivo. Des(rhamnosyl) acteoside is added to an olive extract, whereby high antioxidant activity can be imparted. An acteoside-containing composition is subjected to a glycoside hydrolyzing enzyme treatment, whereby a des(rhamnosyl) acteoside-containing composition can be prepared.
Patent AU-2013217114-B2 (AU)
Title: CD47 antibodies and methods of use thereof
Inventor: ECKELMAN BRENDAN
IPC: C12P21/08
Filed: 2013-02-06
Granted: 2017-03-30
Abstract: This invention relates generally to monoclonal antibodies that recognize CD47, more specifically to CD47 antibodies that do not cause a significant level of agglutination of cells, to methods of generating these antibodies, and to methods of using these monoclonal antibodies as therapeutics.
Patent AU-2013237653-B2 (AU)
Title: Methods and apparatus to control an architectural opening covering assembly
Inventor: COLSON WENDELL B
IPC: E06B9/24
Filed: 2013-10-01
Granted: 2017-11-16
Abstract: Methods and apparatus to control an architectural opening covering assembly are disclosed herein. An example architectural opening covering assembly includes a tube and a covering coupled to the tube such that rotation of the tube winds or unwinds the covering around the tube. A motor is operatively coupled to the tube to rotate the tube. The example architectural opening covering assembly also includes a gravitational sensor to generate tube position information based on a gravity reference. The example architectural opening covering assembly further includes a controller communicatively coupled to the motor to control the motor. The controller is to determine a position of the covering based on the tube position information. (FIG. 1) UYMIN11NU UU V EK1N1Ni A;Ii3V1flL Y Inventors: Colson et. al. Attorney Docket No.: HZ-140.00-353 115, 134 128 126 120 -112 1 l30
Patent AU-2013269597-B2 (AU)
Title: A two-wire controlling and monitoring system for in particular irrigation of localized areas of soil
Inventor: CHRISTIANSEN TOM NOHR
IPC: A01G25/16
Filed: 2013-05-31
Granted: 2016-08-04
Abstract: The present invention relates to a method for providing watering or non-watering of a specific area of soil through a first plurality of irrigation valves (42). Specific irrigation parameters are measured at the specific area of soil through a second plurality of field sensors (54). A controller unit (30) is interconnected to a third plurality of control units (18). Each control unit is connected to a specific irrigation valve and/or a specific field sensor. A type declaration providing communication under a second communication protocol is transmitted from the controller unit to the third plurality of control units using a first communications protocol. A second set of instructions are transmitted from the controller unit to the third plurality of control units using a second communications protocol. A first set of instructions are transmitted from the controller unit to the third plurality of control units using the first communications protocol.
Patent AU-2013281144-B2 (AU)
Title: Amperometric gas sensor
Inventor: SCHENK ELIZABETH H
IPC: G01N27/411
Filed: 2013-04-11
Granted: 2015-11-05
Abstract: The disclosed invention relates to an amperometric gas sensor (10) for measuring the concentration of an analyte, such as hydrogen peroxide, comprising: a solid support (22); and a working electrode (24A) in contact with the solid support (22); wherein the analyte when in contact with the solid support (22) increases the electrical conductivity of the solid support. More particularly, the solid support (22) is made of a electroactive polymeric material, such as a poly (ethylene oxide) polymer complexed with LiSbF6. The monitoring of a sterilization process, such as the disinfection of medical devices, employing the amperometric gas sensor is disclosed.
Patent AU-2013289104-B2 (AU)
Title: Composite materials
Inventor: RESTUCCIO CARMELO LUCA
IPC: B32B7/02
Filed: 2013-04-15
Granted: 2017-07-06
Abstract: A composite material that includes a layer of reinforcing fibres impregnated with a curable resin matrix and a plurality of electrically conductive composite particles positioned adjacent or in proximity to the reinforcing fibres. Each of the electrically conductive composite particles is composed of a conductive component and a polymeric component, wherein the polymeric component includes one or more polymers that are initially in a solid phase and are substantially insoluble in the curable resin, but is able to undergo at least partial phase transition to a fluid phase during a curing cycle of the composite material.
Patent AU-2013305317-B2 (AU)
Title: Duodenum endothelium membrane made by electrostatic spinning
Inventor: WAN PING
IPC: A61F2/04
Filed: 2013-08-18
Granted: 2016-03-17
Abstract: A duodenum endothelium membrane can be obtained from a biocompatible material by electrostatic spinning. The duodenum endothelium membrane is placed into a duodenum, so as to not only block contact of food with an intestinal mucosae anatomically, but also avoid affection on functions of cells of the intestinal mucosae physiologically. The duodenum endothelium membrane can be obtained by hybrid electrospinning or/and multilayer electrospinning or/and core-shell electrospinning or/and dry process electrospinning, and is a medical appliance which can reduce injury, prevent dropping, avoid being removed and restrain bounce and can be used for treating diabetes mellitus and adiposis.
Patent AU-2013312538-B2 (AU)
Title: FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
Inventor: COGAN NOEL
IPC: C12N5/10
Filed: 2013-09-05
Granted: 2019-01-24
Abstract: A method of gene editing or gene stacking within a FAD3 loci by cleaving, in a site directed manner, a location in a FAD3 gene in a cell, to generate a break in the FAD3 gene and then ligating into the break a nucleic acid molecule associated with one or more traits of interest is disclosed.
Patent AU-2013340034-B2 (AU)
Title: Brass alloy and processed part and wetted part
Inventor: TAMEDA HIDENOBU
IPC: C22C9/04
Filed: 2013-04-08
Granted: 2018-03-22
Abstract: Provided is a brass alloy which exhibits excellent recyclability and corrosion resistance while avoiding the addition of Bi and Si, and with which machinability is ensured and processing is facilitated without the inclusion of lead. The present invention includes at least 58.0-63.0 mass% of Cu, 1.0-2.0 mass% of Sn, and 0.05-0.29 mass% of Sb, the remainder comprising Zn and unavoidable impurities. With the present invention, stress corrosion crack resistance and machinability are improved. 0.05-1.5 mass% of Ni is included in a copper alloy to improve stress corrosion crack resistance as a result of the interaction between Ni and Sb. Furthermore, 0.05-0.2 mass% of P is included to improve anti-dezincification properties.
Patent AU-2013368822-B2 (AU)
Title: Enzymatic transesterification/esterification processing systems and processes employing lipases immobilized on hydrophobic resins
Inventor: BASHEER SOBHI
IPC: B01J8/02
Filed: 2013-12-30
Granted: 2017-04-20
Abstract: Disclosed are processing systems and processes for carrying out enzymatic batchwise or continuous process for the production of fatty acid alkyl esters for use in the biofuels, food, cosmetics, pharmaceuticals and detergents industries.
Patent AU-2013369515-B2 (AU)
Title: A cooling device comprising a height adjustable shelf
Inventor: CELIK KADIR RIDVAN
IPC: F25D23/04
Filed: 2013-12-18
Granted: 2016-04-28
Abstract: The present invention relates to a cooling device (1 ) comprising a door (2), more than one support member (3) disposed on the inner surface of the door (2), arranged one below the other and spaced apart along the vertical direction (Y), a height adjustable shelf (4) mounted on the support members (3), a locking mechanism (5) disposed on the shelf (4), having a first position (P1) wherein the locking mechanism (5) enables the height of the shelf (4) to be fixed by interacting with the support member (3) and a second position (P2) wherein the locking mechanism (5) dislodges from the support member (3), enabling the shelf (4) to move on the support members (3) in the vertical direction (Y).